|
|
 |
MYELIN NEWS - October
Myelin News
October 31st, 2011
Published: 10/31/11 | By: Cambridge News
People in Cambridge are being urged to back a fundraising battle on behalf of a young boy suffering from a rare brain disease.
October 26th, 2011
Published: 10/26/2011 | By: Tina Hesman Saey
The spark that ignites multiple sclerosis may come from within. A new study in mice points to normal intestinal bacteria as a trigger for the immune disorder.
October 25th, 2011
Published: 10/25/2011 | Geron Corporation
Non clinical data supports use of GRPOPC1 in Multiple Sclerosis. Read more...
October 24th, 2011
Published: 10/24/2011 | Veronica Greenwood
Sixty years of government-funded basic research has set up a potential revolution in our approach to disease.
October 21st, 2011
Published: 10/21/11 | Brandon Glenn
Athersys (Nasdaq:ATHX) has entered a partnership with a nonprofit multiple sclerosis group to investigate its adult stem cell technology for the treatment of MS. Fast Forward, a nonprofit subsidiary of the National Multiple Sclerosis Society, will commit up to $640,000 to fund animal studies of Athersys’ MultiStem in treating MS, a disease that attacks the central nervous system and can lead to paralysis, according to a statement from Cleveland-based Athersys. Read more...
October 20th, 2011
Published: October 20th, 2011 | By: Journal of Neuroinflammation
Adrenoleukodystrophy (ALD) is an X-linked peroxisomal disorder characterized by the abnormal beta-oxidation of very long chain fatty acids (VLCFA). In 35-40% of children with ALD, an acute inflammatory process occurs in the central nervous system (CNS) leading to demyelination that is rapidly progressive, debilitating and ultimately fatal. Allogeneic hematopoietic stem cell transplantation (HSCT) can halt disease progression in cerebral ALD (C-ALD) if performed early. In contrast, for advanced patients the risk of morbidity and mortality is increased with transplantation. To date there is no means of quantitating neuroinflammation in C-ALD, nor is there an accepted measure to determine prognosis for more advanced patients. Read more...
October 18th, 2011
Published: October 18th, 2011 | By: Amy Docker Marcus
The WSJ reports today that the compound cyclodextrin, found by accident to be apossible therapy for the rare disease Niemann-Pick Type C, is also being tested in a number of other conditions, including Alzheimer’s disease and HIV. But there is also interest in seeing if cyclodextrin might help boys with the rare hereditary neurological disease adrenoleukodystrophy. Read more...
October 16th, 2011
Published: October 13th, 2011 - stem Cell Research News
Scientists have isolated and directed stem cells from the human brain to become oligodendrocytes, the brain cells that make myelin, a crucial fatty material that coats neurons and allows them to signal effectively. Read more...
October 14th, 2011
| Published By: James Mitchell Crow |
New insights into the physical properties of different forms of DNA could help to improve gene therapy, chemists in Spain and India say. Gene therapy aims to cure disease by inserting functional genes into the DNA of living cells, but delivering the DNA into the cell remains a stumbling block. Emilio Aicart, at Universidad Complutense in Madrid, Santanu Bhattacharya, at the Indian Institute of Science in Bangalore, and colleagues say that their findings can explain why some types of DNA can transfect cells more efficiently than others.
Scientists have claimed that they have done a breakthrough in treating genetic disorder by using both stem cell and gene therapy combined and found succeeded in their initial stage. So far, genetic disorders could not be treated with stem cells created from the patient himself since the stem cells taken from the patient itself will contain the corrupted genetic code.
Published By: Health Destination, October 14th, 2011
October 13th, 2011
By: Ellen Goldbaum
Published: October 13th, 2011
Researchers at the Hopkins School of Medicine have discovered a link between electrical stimulation and the ability to repair damaged brain matter. Focusing on an important type of brain cell called oligodendrocytes, they were able to build on previous research involving electrical stimulation and recovery of damaged brain tissue.
By: Vivek Sinanan
Published: October 13th, 2011
Researchers at the Hopkins School of Medicine have discovered a link between electrical stimulation and the ability to repair damaged brain matter. Focusing on an important type of brain cell called oligodendrocytes, they were able to build on previous research involving electrical stimulation and recovery of damaged brain tissue.
By: James Gallagher, Health Reporter, BBC News
Published: October 13th, 2011
Two of the holy grails of medicine - stem cell technology and precision gene therapy - have been united for the first time in humans, say scientists.
October 6th, 2011
October 4th, 2011
MRI scan: This image shows the brain of a
patient who is suffering from multiple sclerosis.
Posted By: Sarah Long on Oct. 4th, 2011 2:54 p.m.
October 3rd, 2011
Source: Sheela Philomena
Source: James M. Wilson, M.D., Ph.D.
Source: Nationwide Children's Hospital
October 2nd, 2011
"Breakthrough in Understanding Brain Mechanism Drug Discovery and Development"
"New Technology Transforms Mouse Stem Cells Into Trillions of Myelinating Cells"
|
|
|
|
OPML |
Search This Site |
Home
![[ photograph ]](http://www.buffalo.edu/news/thumbnails/Fraser-Sim-Stem-Cells.jpg)
